A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 10 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2019.
- 10 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 01 Apr 2016 Planned End Date changed from 1 Nov 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov.